BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36562381)

  • 21. Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis.
    Hu L; Liu J; Shimada H; Ito M; Sugimoto K; Hiwasa T; Zhou Q; Li J; Shen S; Wang H
    Front Oncol; 2022; 12():870086. PubMed ID: 35656505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.
    Okami J; Dohno K; Sakon M; Iwao K; Yamada T; Yamamoto H; Fujiwara Y; Nagano H; Umeshita K; Matsuura N; Nakamori S; Monden M
    Clin Cancer Res; 2000 Jun; 6(6):2326-32. PubMed ID: 10873083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus.
    Kawashima R; Abei M; Fukuda K; Nakamura K; Murata T; Wakayama M; Seo E; Hasegawa N; Mizuguchi H; Obata Y; Hyodo I; Hamada H; Yokoyama KK
    Int J Cancer; 2011 Sep; 129(5):1244-53. PubMed ID: 21710497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Movement of a novel serum tumour marker, RCAS1, in patients with biliary diseases.
    Enjoji M; Yamaguchi K; Nakamuta M; Nakashima M; Kotoh K; Tanaka M; Nawata H; Watanabe T
    Dig Liver Dis; 2004 Sep; 36(9):622-7. PubMed ID: 15460847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological identification of Tektin5 as a cancer/testis antigen and its immunogenicity.
    Hanafusa T; Mohamed AE; Domae S; Nakayama E; Ono T
    BMC Cancer; 2012 Nov; 12():520. PubMed ID: 23151147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular cloning and characterization of human WNT7B.
    Kirikoshi H; Sekihara H; Katoh M
    Int J Oncol; 2001 Oct; 19(4):779-83. PubMed ID: 11562755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning.
    Vaughan HA; St Clair F; Scanlan MJ; Chen YT; Maraskovsky E; Sizeland A; Old LJ; Cebon J
    Cancer Immun; 2004 Jul; 4():5. PubMed ID: 15255672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy.
    Lee DW; Im SA; Kim YJ; Yang Y; Rhee J; Na II; Lee KH; Kim TY; Han SW; Choi IS; Oh DY; Kim JH; Kim TY; Bang YJ
    Cancer Res Treat; 2017 Jul; 49(3):807-815. PubMed ID: 28111425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor associated antigen recognition by autologous serum in patients with breast cancer.
    Qian F; Odunsi K; Blatt LM; Scanlan MJ; Mannan M; Shah N; Montgomery J; Haddad F; Taylor M
    Int J Mol Med; 2005 Jan; 15(1):137-44. PubMed ID: 15583840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer.
    Dhar DK; Olde Damink SW; Brindley JH; Godfrey A; Chapman MH; Sandanayake NS; Andreola F; Mazurek S; Hasan T; Malago M; Pereira SP
    Cancer; 2013 Feb; 119(3):575-85. PubMed ID: 22864959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
    Jäger D; Unkelbach M; Frei C; Bert F; Scanlan MJ; Jäger E; Old LJ; Chen YT; Knuth A
    Cancer Immun; 2002 Jun; 2():5. PubMed ID: 12747750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.
    Kim HJ; Kim MH; Myung SJ; Lim BC; Park ET; Yoo KS; Seo DW; Lee SK; Min YI
    Am J Gastroenterol; 1999 Jul; 94(7):1941-6. PubMed ID: 10406263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of tumor-associated autoantigens with SEREX.
    Türeci O; Usener D; Schneider S; Sahin U
    Methods Mol Med; 2005; 109():137-54. PubMed ID: 15585919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases.
    Yoshida Y; Zhang XM; Wang H; Machida T; Mine S; Kobayashi E; Adachi A; Matsutani T; Kamitsukasa I; Wada T; Aotsuka A; Iwase K; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Takizawa H; Kashiwado K; Shin H; Akaogi Y; Shimada J; Nishi E; Ohno M; Takemoto M; Yokote K; Kitamura K; Iwadate Y; Hiwasa T
    Heliyon; 2020 Aug; 6(8):e04661. PubMed ID: 32904265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
    Preuss KD; Zwick C; Bormann C; Neumann F; Pfreundschuh M
    Immunol Rev; 2002 Oct; 188():43-50. PubMed ID: 12445280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX).
    Machida T; Kubota M; Kobayashi E; Iwadate Y; Saeki N; Yamaura A; Nomura F; Takiguchi M; Hiwasa T
    J Transl Med; 2015 Feb; 13():71. PubMed ID: 25890248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas.
    Matsutani T; Hiwasa T; Takiguchi M; Oide T; Kunimatsu M; Saeki N; Iwadate Y
    J Exp Clin Cancer Res; 2012 Oct; 31(1):85. PubMed ID: 23050879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries.
    Behrends U; Schneider I; Rössler S; Frauenknecht H; Golbeck A; Lechner B; Eigenstetter G; Zobywalski C; Müller-Weihrich S; Graubner U; Schmid I; Sackerer D; Späth M; Goetz C; Prantl F; Asmuss HP; Bise K; Mautner J
    Int J Cancer; 2003 Aug; 106(2):244-51. PubMed ID: 12800201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Verification of WFA-Sialylated MUC1 as a Sensitive Biliary Biomarker for Human Biliary Tract Cancer.
    Yamaguchi T; Yokoyama Y; Ebata T; Matsuda A; Kuno A; Ikehara Y; Shoda J; Narimatsu H; Nagino M
    Ann Surg Oncol; 2016 Feb; 23(2):671-7. PubMed ID: 26416714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.
    Kato N; Yamamoto H; Adachi Y; Ohashi H; Taniguchi H; Suzuki H; Nakazawa M; Kaneto H; Sasaki S; Imai K; Shinomura Y
    World J Gastroenterol; 2013 Mar; 19(11):1718-27. PubMed ID: 23555160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.